Found 36 results
Filters: Author is Walker, Bruce D  [Clear All Filters]
Radebe M, Gounder K, Mokgoro M, Ndhlovu ZM, Mncube Z, Mkhize L, van der Stok M, Jaggernath M, Walker BD, Ndung'u T.  2015.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.. AIDS. 29(1):23-33.
Heesters BA, Lindqvist M, Vagefi PA, Scully EP, Schildberg FA, Altfeld M, Walker BD, Kaufmann DE, Carroll MC.  2015.  Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes.. PLoS Pathog. 11(12):e1005285.
Gounder K, Padayachi N, Mann JK, Radebe M, Mokgoro M, van der Stok M, Mkhize L, Mncube Z, Jaggernath M, Reddy T et al..  2015.  High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection.. PLoS One. 10(3):e0119886.
Ranasinghe S, Soghoian DZ, Lindqvist M, Ghebremichael M, Donaghey F, Carrington M, Seaman MS, Kaufmann DE, Walker BD, Porichis F.  2015.  HIV-1 antibody neutralization breadth is associated with enhanced HIV-specific CD4+ T cell responses.. J Virol.
Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, Hahn BH, Czartoski JL, McElrath JM, Lehmann C et al..  2015.  HIV-1 Integration Landscape during Latent and Active Infection.. Cell. 160(3):420-32.
Freund NT, Horwitz JA, Nogueira L, Sievers SA, Scharf L, Scheid JF, Gazumyan A, Liu C, Velinzon K, Goldenthal A et al..  2015.  A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.. PLoS Pathog. 11(10):e1005238.
Martin-Gayo E, Buzon MJose, Ouyang Z, Hickman T, Cronin J, Pimenova D, Walker BD, Lichterfeld M, Yu XG.  2015.  Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.. PLoS Pathog. 11(6):e1004930.
Caskey M, Klein F, Lorenzi JCC, Seaman MS, West AP, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF et al..  2015.  Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.. Nature. 522(7557):487-91.
Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath JM, Nussenzweig MC, Pulendran B et al..  2012.  A Blueprint for HIV Vaccine Discovery.. Cell Host Microbe. 12(4):396-407.
Klein F, Gaebler C, Mouquet H, Sather ND, Lehmann C, Scheid JF, Kraft Z, Liu Y, Pietzsch J, Hurley A et al..  2012.  Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein.. J Exp Med. 209(8):1469-79.
Matthews PC, Koyanagi M, Kløverpris HN, Harndahl M, Stryhn A, Akahoshi T, Gatanaga H, Oka S, Molina C J, Ponce H V et al..  2012.  Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.. J Virol.
Walker BD.  2012.  "Elite controllers" provide clues to keeping HIV infection in check. Interview by Tracy Hampton.. JAMA. 308(4):328-9.
Stephenson KE, Li H, Walker BD, Michael NL, Barouch DH.  2012.  Gag-Specific Cellular Immunity Determines In Vitro Viral Inhibition and In Vivo Virologic Control following Simian Immunodeficiency Virus Challenges of Vaccinated Rhesus Monkeys.. J Virol. 86(18):9583-9.
Goulder PJR, Walker BD.  2012.  HIV and HLA Class I: An Evolving Relationship.. Immunity. 37(3):426-40.
Kløverpris HN, Harndahl M, Leslie AJ, Carlson JM, Ismail N, van der Stok M, Huang K-H G, Chen F, Riddell L, Steyn D et al..  2012.  HIV control through a single nucleotide on the HLA-B locus.. J Virol.
McElrath JM, Walker BD.  2012.  Is an HIV vaccine possible? J Acquir Immune Defic Syndr. 60 Suppl 2:S41-3.